Moc-L-Tert-Leucine CAS 162537-11-3 Kuchena ≥99.0% (HPLC) Atazanavir Intermediate Factory
Mugadziri Wekutengesa ane Kuchena Kwepamusoro uye Hunhu Hwakagadzikana
Zita reKemikari: Moc-L-Tert-Leucine
CAS: 162537-11-3
Pakati peAtazanavir HIV-1 Protease Inhibitor
High Quality, Commercial Production
Chemical Name | Moc-L-Tert-Leucine |
Mashoko anoreva zvakafanana | Methoxycarbonyl-L-tert-Leucine;N-(Methoxycarbonyl) -tert-Leucine;Atazanavir Inoenderana Musanganiswa A |
Nhamba yeCAS | 162537-11-3 |
Nhamba yeCAT | RF-PI289 |
Stock Status | MuStock, Kugadzirwa Kunokwira Kusvika Matani |
Molecular Formula | C8H15NO4 |
Molecular Weight | 189.21 |
Melting Point | 109℃ |
Density | 1.126 g/cm3 |
Boiling Point | 320.9 ℃ pa760 mmHg |
Solubility | Soluble muEthyl Acetate uye Methanol |
Shipping Condition | Yakatumirwa Pasi peAmbient Temperature |
Brand | Ruifu Chemical |
Item | Zvinotsanangurwa |
Chitarisiko | Machena kusvika Kusina-Machena Makristasi |
Nzira dzekuzivikanwa | HPLC |
Kuchena/Kuongorora Nzira | ≥99.0% (HPLC) |
Moc-L-Tle-Tle-OH | ≤0.30% |
L-Moc-Dimer | ≤0.30% |
L-Tle-OH | ≤0.10% |
Methoxycarbonyl-L-Valine | ≤0.10% |
N-Acetyl-L-tert-Leucine | ≤0.05% |
Individual Unkown Kusachena | ≤0.30% |
Zvose Zvisina Kuchena | ≤1.0% |
Enantiomer Content | ≤0.10% (By Chiral HPLC) |
Mvura Yemukati | ≤0.50% (NeKF) |
Kurasika paKuomesa | ≤0.50% |
Residue paIgnition | ≤0.20% |
Heavy Metals | ≤10ppm |
Usage | Amino Acid;Pakati peAtazanavir (CAS 198904-31-3) |
Package: Bhodhoro, Aluminium foil bag, 25kg/Drum, kana zvinoenderana nezvinodiwa nemutengi.
Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza, unyoro.
Shanghai Ruifu Chemical Co., Ltd. ndiyo inotungamira mugadziri uye mutengesi weMoc-L-Tert-Leucine (CAS 162537-11-3) ine mhando yepamusoro.Moc-L-Tert-Leucine imhando yeamino acid inobuda.Inobatsira zvikuru yepakati pakuita zvakanaka kuumbwa kweHIV protease inhibitor Atazanavir (CAS 198904-31-3) pamwe neAtazanavir sulfate (CAS 229975-97-7).
Atazanavir iantiretroviral agent yakatenderwa neFDA kuti ishandiswe pamwe nemamwe maanti-RTagents ekurapa utachiona hweHIV.Mushonga unogara uchishandiswa pamwe chete neRT inhibitors.Atazanavir inhibitor yeHIV-1 protease (EC50=2.6 nM).Mumaseru ari ega, ane anowedzera kune zvine mwero synergistic antiviral mhedzisiro kana yasanganiswa nemamwe maantiretroviral zvinodhaka.Nekuda kweizvozvo, inowanzoshandiswa mu vivo mumubatanidzwa kurapa hutachiona hweHIV-1.